Selected Publications
Sharma A, Kang G, Sunkara A, Inaba H, Jeha S, Cross SJ, Geiger T, Triplett B. Haploidentical Donor Transplantation Using a Novel Clofarabine-Containing Conditioning Regimen for Very High-Risk Hematologic Malignant Neoplasms. Journal Pediatric Hematology Oncology 40:e479-e485, 2018. PMID:29750747. DOI: 10.1097/MPH.0000000000001222
Triplett BM, Muller B, Kang G, Li Y, Cross SJ, Moen J, Cunningham L, Janssen W, Mamcarz E, Shook DR, Srinivasan A, Choi JK, Hayden RT, Leung W. Selective T-cell depletion targeting CD45RA reduces viremia and enhances early T-cell recovery compared to CD3-targeted T-cell depletion. Transplant Infectious Disease Feb;20(1), 2018. PMID: 29178554. DOI: 10.1111/tid.12823
Triplett BM, Shook DR, Eldridge P, Li Y, Kang G, Dallas M, Hartford C, Srinivasan S, Chan WK, Suwannasaen D, Inaba H, Merchant TE, Pui CH, Leung W. Early Immune Reconstitution Recapitulating CD45RA-depleted Haploidentical Graft Content in Patients with Hematologic Malignancies. Bone Marrow Transplantation 50(7):968-977, 2015. PubMed PMID: 25665048; DOI: 10.1038/bmt.2014.324
Triplett B, Handgretinger R, Pui CH, Leung W. KIR-incompatible hematopoietic-cell transplantation for poor prognosis infant acute lymphoblastic leukemia. Blood 107(3):1238-9, 2006. PubMed PMID: 19212329, DOI: 10.1038/leu.2009.21
Last update: November 2018